Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCT197 for AKI Prevention in Cardiac Surgery
NCT01336959Phase 2Terminated
- Sponsor
- Mereo BioPharma
- Start
- Sep 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of acumapimod in acute kidney injury (AKI), sponsored by Mereo BioPharma. Started Sep 2011; status: terminated.
02
Drugs
acumapimod
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01336959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336959.